Pillstats
Rx only · Tablet · Oral

Lisinopril And Hydrochlorothiazide

Brands: Zestoretic · Hydrochlorothiazide + Lisinopril

18 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US52 NDCs
18 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)29046
US makers18 labelers
Packages137
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 16 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.011$0.022$0.033$0.044Dec 2025Apr 2026Jul 2026
$0.035
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
18
Active US suppliers
31%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

113K227K340K454K2025 Q12025 Q22025 Q32025 Q42026 Q1
318K
Rx · 2026 Q1
19.0M
Units dispensed
-19%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it18 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager23SUPPLYING
Proficient Rx LPunknown19SUPPLYING
NuCare Pharmaceuticals, Inc.unknown15SUPPLYING
Preferred Pharmaceuticals Inc.unknown12SUPPLYING
Lupin Pharmaceuticals,Inc.unknown9SUPPLYING
Northwind Health Company, LLCunknown9SUPPLYING
A-S Medication Solutionsunknown8SUPPLYING
REMEDYREPACK INC.repackager7SUPPLYING
GSMS, Incorporatedunknown6SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown6SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown6SUPPLYING
Actavis Pharma, Inc.unknown6SUPPLYING
Legacy Pharmaceutical Packaging, LLCunknown3SUPPLYING
Almatica Pharma LLCunknown3SUPPLYING
QPharma Incunknown2SUPPLYING

+ 3 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 20, 2025
    RECALLRecall (Class II): Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals…

    Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide within the United States.

  • Jan 26, 2022
    RECALLRecall (Class II): Lisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg, Rx only, 100 Tablets per bottles, Manufactured for: Lupin …

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA

  • Jul 19, 2019
    RECALLRecall (Class II): Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for: Lupin Pharm…

    Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States

  • Jul 17, 2019
    RECALLRecall (Class II): Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg, 100 tablet bottle, Rx only, Manufactured by for: Lupin P…

    Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to wholesalers/distributors and supermarket and drug chains throughout the United States.

  • Apr 4, 2016
    RECALLRecall (Class III): Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, packaged in a)100-count bottles and b) 5000-count bottles, Rx…

    CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide and Puerto Rico